|
【结 构 式】
|
【药物名称】Holmium-166-DOTMP , 166Ho-DOTMP 【化学名称】1,1',1'',1'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylphosphonic acid) 166holmium complex 【CA登记号】 【 分 子 式 】C12H32HoN4O12P4 【 分 子 量 】714.30364 |
【开发单位】International Isotopes (Supplier), Aventis Pharma (Originator), NeoRx (Licensee) 【药理作用】Multiple Myeloma Therapy, Oncolytic Drugs, Radiation Therapy |
合成路线1
The reaction of 1,4,7,10-tetraazacyclododecane (I) with formaldehyde and phosphoric acid in refluxing aqueous HCl gives the tetraphosphonic acid (II), which is then treated with aqueous 166HoCl3 to obtain the target chelate.

| 【1】 Simon, J.; Garlich, J.R.; Wilson, D.A.; McMillan, K. (Marion Merrell Dow, Inc.); Bone marrow suppressing agents. EP 0374501; JP 1990237936; US 4882142 . |
Extended Information